Cellular and metabolic functions for autophagy in cancer cells

Trends in Cell Biology

Volumn 25, Issue 1, 2015, Pages 37-45

  Kenific, Candia M ^a   Debnath, Jayanta ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anoikis; Autophagy; Cancer; Invasion; Metabolism; Unfolded protein response

Indexed keywords

ANOIKIS; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL FUNCTION; CELL INVASION; CELL MATURATION; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; METASTASIS; NONHUMAN; REVIEW; UNFOLDED PROTEIN RESPONSE; ANIMAL; DISEASE COURSE; DISEASE MODEL; METABOLISM; MOUSE; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; CARCINOGENESIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; METABOLISM; MICE; NEOPLASMS; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

EID: 84918827750     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2014.09.001     Document Type: Review

References (88)

1. Reggiori F., Klionsky D.J. Autophagic processes in yeast: mechanism, machinery and regulation. Genetics 2013, 194:341-361.
2. Yang Z., Klionsky D.J. Mammalian autophagy: core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 2010, 22:124-131.
3. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009, 43:67-93.
4. Murrow L., Debnath J. Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. Annu. Rev. Pathol. 2013, 8:105-137.
5. Kimmelman A.C. The dynamic nature of autophagy in cancer. Genes Dev. 2011, 25:1999-2010.
6. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 2012, 12:401-410.
7. Guo J.Y., et al. Autophagy-mediated tumor promotion. Cell 2013, 155:1216-1219.
8. Yue Z., et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15077-15082.
9. Qu X., et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 2003, 112:1809-1820.
10. Aita V.M., et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999, 59:59-65.
11. Liang X.H., et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
12. Laddha S.V., et al. Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol. Cancer Res. 2014, 12:485-490.
13. Takamura A., et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 2011, 25:795-800.
14. Inami Y., et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J. Cell Biol. 2011, 193:275-284.
15. Rao S., et al. A dual role for autophagy in a murine model of lung cancer. Nat. Commun. 2014, 5:3056.
16. Rosenfeldt M.T., et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 2013, 504:296-300.
17. Yang A., et al. Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov. 2014, 4:905-913.
18. Strohecker A.M., et al. Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov. 2013, 3:1272-1285.
19. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012, 21:297-308.
20. Lock R., et al. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol. Biol. Cell 2011, 22:165-178.
21. Wei H., et al. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev. 2011, 25:1510-1527.
22. Guo J.Y., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011, 25:460-470.
23. Yang S., et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011, 25:717-729.
24. Guo J.Y., et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev. 2013, 27:1447-1461.
25. Karsli-Uzunbas G., et al. Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov. 2014, 4:914-927.
26. Levy J.M., et al. Autophagy inhibition improves chemosensitivity in BRAFV600E brain tumors. Cancer Discov. 2014, 4:773-780.
27. Roberts D.J., et al. Hexokinase-II positively regulates glucose starvation-induced autophagy through TORC1 inhibition. Mol. Cell 2014, 53:521-533.
28. Yang Z., et al. Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J. Exp. Med. 2013, 210:2119-2134.
29. Hu S., et al. 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. Cell Metab. 2011, 14:131-142.
30. Li Z., Graham B.H. Measurement of mitochondrial oxygen consumption using a Clark electrode. Methods Mol. Biol. 2012, 837:63-72.
31. Gardner B.M., et al. Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harb. Perspect. Biol. 2013, 5:a013169.
32. Hart L.S., et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J. Clin. Invest. 2012, 122:4621-4634.
33. Nagy P., et al. Myc-driven overgrowth requires unfolded protein response-mediated induction of autophagy and antioxidant responses in Drosophila melanogaster. PLoS Genet. 2013, 9:e1003664.
34. Rouschop K.M., et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J. Clin. Invest. 2010, 120:127-141.
35. Pike L.R., et al. Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival. Biochem. J. 2013, 449:389-400.
36. Avivar-Valderas A., et al. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol. Cell. Biol. 2011, 31:3616-3629.
37. Ma X.H., et al. Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. J. Clin. Invest. 2014, 124:1406-1417.
38. Miller D.M., et al. c-Myc and cancer metabolism. Clin. Cancer Res. 2012, 18:5546-5553.
39. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
40. Sethi N., Kang Y. Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat. Rev. Cancer 2011, 11:735-748.
41. Paoli P., et al. Anoikis molecular pathways and its role in cancer progression. Biochim. Biophys. Acta 2013, 1833:3481-3498.
42. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147:992-1009.
43. Reymond N., et al. Crossing the endothelial barrier during metastasis. Nat. Rev. Cancer 2013, 13:858-870.
44. Fung C., et al. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol. Biol. Cell 2008, 19:797-806.
45. Chen N., et al. Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture. Oncogene 2013, 32:2543-2554.
46. Peng Y.F., et al. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Autophagy 2013, 9:2056-2068.
47. Macintosh R.L., et al. Inhibition of autophagy impairs tumor cell invasion in an organotypic model. Cell Cycle 2012, 11:2022-2029.
48. Galavotti S., et al. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene 2013, 32:699-712.
49. Beckner M.E., et al. Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas. Int. J. Cancer 2010, 126:2282-2295.
50. Li J., et al. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. Carcinogenesis 2013, 34:1343-1351.
51. Lock R., et al. Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov. 2014, 4:466-479.
52. Zhan Z., et al. Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination. Autophagy 2014, 10:257-268.
53. Deretic V., et al. Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation. Trends Cell Biol. 2012, 22:397-406.
54. O'Reilly S., et al. Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-beta (TGF-beta) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J. Biol. Chem. 2014, 289:9952-9960.
55. Qiang L., et al. Regulation of cell proliferation and migration by p62 through stabilization of Twist1. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:9241-9246.
56. Tsai J.H., Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013, 27:2192-2206.
57. Rogov V., et al. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol. Cell 2014, 53:167-178.
58. Mancias J.D., et al. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 2014, 509:105-109.
59. Puissant A., et al. When autophagy meets cancer through p62/SQSTM1. Am. J. Cancer Res. 2012, 2:397-413.
60. Komatsu M., et al. p62/SQSTM1/A170: physiology and pathology. Pharmacol. Res. 2012, 66:457-462.
61. Duran A., et al. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 2008, 13:343-354.
62. Ling J., et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 2012, 21:105-120.
63. Mathew R., et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137:1062-1075.
64. Wei H., et al. p62/SQSTM1 synergizes with autophagy for tumor growth in vivo. Genes Dev. 2014, 28:1204-1216.
65. Komatsu M., et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 2010, 12:213-223.
66. Ichimura Y., et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell 2013, 51:618-631.
67. Duran A., et al. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol. Cell 2011, 44:134-146.
68. Linares J.F., et al. K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells. Mol. Cell 2013, 51:283-296.
69. Newman A.C., et al. TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-kappaB signalling. PLoS ONE 2012, 7:e50672.
70. Liu Z., et al. Ubiquitylation of autophagy receptor Optineurin by HACE1 activates selective autophagy for tumor suppression. Cancer Cell 2014, 26:106-120.
71. Zhu G., et al. Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr. Biol. 2007, 17:1438-1443.
72. Rubio N., et al. p38(MAPK)-regulated induction of p62 and NBR1 after photodynamic therapy promotes autophagic clearance of ubiquitin aggregates and reduces reactive oxygen species levels by supporting Nrf2-antioxidant signaling. Free Radic. Biol. Med. 2014, 67:292-303.
73. Kuo T.C., et al. Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity. Nat. Cell Biol. 2011, 13:1214-1223.
74. Amaravadi R.K., et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 2011, 17:654-666.
75. Barnard R.A., et al. Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Autophagy 2014, 10:1415-1425.
76. Mahalingam D., et al. Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors. Autophagy 2014, 10:1403-1414.
77. Rangwala R., et al. Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy 2014, 10:1391-1402.
78. Rangwala R., et al. Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy 2014, 10:1369-1379.
79. Rosenfeld M.R., et al. A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy 2014, 10:1359-1368.
80. Vogl D.T., et al. Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. Autophagy 2014, 10:1380-1390.
81. Wolpin B.M., et al. Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. Oncologist 2014, 19:637-638.
82. Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr. Opin. Cell Biol. 2010, 22:132-139.
83. Chan E.Y. mTORC1 phosphorylates the ULK1-mAtg13-FIP200 autophagy regulatory complex. Sci. Signal. 2009, 2:pe51.
84. Itakura E., et al. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol. Biol. Cell 2008, 19:5360-5372.
85. Geng J., Klionsky D.J. The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep. 2008, 9:859-864.
86. Klionsky D.J., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
87. Shen H.M., Mizushima N. At the end of the autophagic road: an emerging understanding of lysosomal functions in autophagy. Trends Biochem. Sci. 2014, 39:61-71.
88. Ao X., et al. Regulation of autophagy by the Rab GTPase network. Cell Death Differ. 2014, 21:348-358.